Zdrowie i gospodarka · 23/07/1999

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

The Food and Drug Administration (FDA) is announcing that it has submitted a request for the Office of Management and Budget (OMB) to review and clear the collection of information related to the dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices. This request is part of the Paperwork Reduction Act of 1995 (PRA) process.